Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study With Blinded Assessment to Evaluate the Safety and Effectiveness of the Tixel C Fractional System in the Treatment of Acne Scars

NCT04269317 is registered in ClinicalTrials.gov with Novoxel Ltd. as lead sponsor.

NCT NCT04269317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04269317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study With Blinded Assessment to Evaluate the Safety and Effectiveness of the Tixel C Fractional System in the Treatment of Acne Scars
Lead sponsor
Novoxel Ltd.
Phase
Not applicable
Overall status
Withdrawn
Start date
March 1, 2020
Completion date
January 10, 2021
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

scars